Although previous studies reported that CCL2 could be transactivated by several transcriptional factors such as NF-κB, STAT3, STAT1, Twist1, and ETS140, we confirmed in the present study that ETV5-activated STAT3 could enhance CCL2 transcription in CRC. The gene discussed is STAT1; the disease is colorectal carcinoma.